Armata Pharmaceuticals (ARMP) Cash from Investing Activities (QoQ) (2013 - 2026)
Armata Pharmaceuticals (ARMP) Cash from Investing Activities (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Armata Pharmaceuticals | 187.95 Mn | 183.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.15% |
| Dec 31, 2025 | 78.51% |
| Sep 30, 2025 | -62.42% |
| Jun 30, 2025 | -50.51% |
| Mar 31, 2025 | -228.57% |
| Dec 31, 2024 | 122.65% |
| Sep 30, 2024 | 75.11% |
| Jun 30, 2024 | -446.40% |
| Mar 31, 2024 | 89.54% |
| Dec 31, 2023 | 31.95% |
| Sep 30, 2023 | -1,481.98% |
| Jun 30, 2023 | 88.96% |
| Mar 31, 2023 | -541.76% |
| Dec 31, 2022 | 135.16% |
| Sep 30, 2022 | -13.91% |
| Jun 30, 2022 | -381.36% |
| Mar 31, 2022 | -3.51% |
| Dec 31, 2021 | 60.82% |
| Sep 30, 2021 | -196.94% |
| Jun 30, 2021 | 34.23% |